What evidence supports the use of ivermectin in cancer treatment, and how is the quality of this evidence rated?
Abstract
Ivermectin demonstrates potential anticancer properties in preclinical models, but current evidence is insufficient for its use in clinical oncology due to the lack of robust human trials and translational research.
Fields of Study & Subjects
Parasitic Diseases Research and Treatment
Cancer therapeutics and mechanisms
Bioactive Compounds and Antitumor Agents
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 29 January 2026